{{Rsnum
|rsid=3806929
|Gene=FGF18
|Chromosome=5
|position=171418055
|Orientation=minus
|GMAF=0.432
|Gene_s=FGF18
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 40.7 | 15.0
| HCB | 19.0 | 50.4 | 30.7
| JPT | 25.7 | 37.2 | 37.2
| YRI | 38.1 | 49.7 | 12.2
| ASW | 38.6 | 45.6 | 15.8
| CHB | 19.0 | 50.4 | 30.7
| CHD | 24.8 | 44.0 | 31.2
| GIH | 32.7 | 44.6 | 22.8
| LWK | 30.0 | 41.8 | 28.2
| MEX | 31.0 | 56.9 | 12.1
| MKK | 35.9 | 46.2 | 17.9
| TSI | 37.3 | 52.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=24146310
|Title=Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}